https://e-journal.unmas.ac.id/index.php/Medicamento <p><a title="Profil Sinta JINTO" href="https://sinta.kemdikbud.go.id/journals/profile/7980" target="_blank" rel="noopener"><strong>Jurnal Ilmiah Medicamento</strong></a> abbreviated as <em>JINTO</em>, with the registered e-ISSN <a title="e-ISSN Jurnal Ilmiah Medicamento" href="https://issn.brin.go.id/terbit/detail/1409274190" target="_blank" rel="noopener">2356-4814</a>, is an <strong>open-access</strong> scientific journal in the field of pharmacy. Each and every manuscript in this journal is reviewed by two reviewers and conducted through a <em><strong>double-blind peer review</strong></em> system to ensure objectivity and high quality assessment. JINTO has been accredited by ARJUNA with a <a href="https://drive.google.com/file/d/1Vd3DsOLOw5PUVxJOtpRo5NYBkbhcef5G/view?usp=sharing" target="_blank" rel="noopener"><strong>SINTA 4</strong></a> ranking from Vol.5 No.1 in 2019 until Vol.9 No.2 in 2023. Starting from Vol.9 No.1 in 2023, the journal has been elevated to a <a href="https://drive.google.com/file/d/1jk-jJuFhmSvbfim1lPX5-HUY7J-hIux4/view?usp=sharing" target="_blank" rel="noopener"><strong>SINTA 2</strong></a> accreditation, as per the Decree of the Director General of Higher Education, Research, and Technology, Ministry of Education, Culture, Research, and Technology of the Republic of Indonesia, Number <a href="https://drive.google.com/file/d/1jk-jJuFhmSvbfim1lPX5-HUY7J-hIux4/view?usp=sharing" target="_blank" rel="noopener">177/E/KPT/2024</a>, dated October 15, 2024.</p> <p>Initially published by the Akademi Farmasi Saraswati Denpasar, the journal transitioned to being published by the <a title="Fakultas Farmasi Universitas Mahasaraswati Denpasar" href="http://farmasi.unmas.ac.id/" target="_blank" rel="noopener"><strong>Faculty of Pharmacy, Universitas Mahasaraswati Denpasar</strong>,</a> in early 2019 following the integration of the academy into the university as its Faculty of Pharmacy.</p> <p>JINTO is published biannually in <strong>March</strong> and <strong>September</strong> and aims to disseminate current scientific knowledge to researchers in the pharmacy field. The journal accepts original research articles and review articles encompassing <strong>various areas of pharmaceutical science</strong>, including <em>Pharmacology and Toxicology</em>; <em>Clinical and Community Pharmacy</em>; <em>Pharmaceutical Chemistry and Analysis</em>; <em>Pharmaceutical Biology and Natural Products</em>; <em>Pharmaceutical Technology</em>; <em>Pharmaceutical Microbiology and Biotechnology</em>; <em>Regulatory Affairs and Pharmacy Marketing Research</em>; and <em>Alternative medicine</em>.</p> en-US https://e-journal.unmas.ac.id/index.php/Medicamento/announcement/view/43 <p>Dear authors and readers,</p> <p>We would like to inform you that starting from the 2025 edition, <strong>Jurnal Ilmiah Medicamento</strong> will implement a<a href="https://docs.google.com/document/d/1aXzEM1mCJTcrrEv8WJ6be5HR98-Q_zN1/edit?usp=sharing&amp;ouid=116962304450954466793&amp;rtpof=true&amp;sd=true" target="_blank" rel="noopener"> new manuscript template</a> to enhance publication quality and article formatting standards.</p> <p>Authors submitting manuscripts for the 2025 edition and beyond are required to use the updated template, which can be downloaded from the journal’s official website.</p> <p>We kindly ask all authors to ensure their manuscripts adhere to the new format before submission. If you have any questions or encounter any difficulties using the new template, please contact our editorial team at medicamento@unmas.ac.id </p> <p>Thank you for your attention and cooperation.</p> <p>Editorial Team of Jurnal Ilmiah Medicamento.</p> Jurnal Ilmiah Medicamento 2025-02-15 https://e-journal.unmas.ac.id/index.php/Medicamento/announcement/view/38 <p>Based on the results of the Scientific Journal Accreditation for Period II of 2024 and the issuance of the Decree of the Director General of Higher Education, Research, and Technology, Ministry of Education, Culture, Research, and Technology of the Republic of Indonesia <a title="JINTO reaccreditation" href="https://drive.google.com/file/d/1jk-jJuFhmSvbfim1lPX5-HUY7J-hIux4/view?usp=sharing" target="_blank" rel="noopener">Number: 177/E/KPT/2024 dated October 15, 2024,</a> regarding the Accreditation Ranking of Scientific Journals for Period II of 2024, the <strong>Jurnal Ilmiah Medicamento</strong> has achieved an improved ranking, moving from SINTA 4 accreditation to <strong>SINTA 2</strong> accreditation, applicable from Volume 9, Issue 1 of 2023 to Volume 13, Issue 2 of 2027.</p> Jurnal Ilmiah Medicamento 2024-11-26 https://e-journal.unmas.ac.id/index.php/Medicamento/announcement/view/12 <p>Dear all users and authors of the <strong>Jurnal Ilmiah Medicamento</strong>.</p> <p>As of 2025, the JINTO Editorial Board has decided to apply a publication fee for each article that has been accepted and will be published at JINTO of <strong>Rp 1,200,002</strong> (IDR).</p> <p><strong>All manuscripts that have been submitted to OJS JINTO before this notification</strong> <strong>will be subject to the new policy above if it has been decided to be accepted and will be published at JINTO in 2025.</strong></p> <p><strong>Article Submission and Processing Fees remain free of charge.</strong></p> Jurnal Ilmiah Medicamento 2022-12-06